| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/09/2008 | EP1941909A1 Preventives/remedies for cancer |
| 07/09/2008 | EP1941904A2 Anti-TNF antibodies and methotrexate in the treatment of autoimmune diseases |
| 07/09/2008 | EP1941894A1 Isoflavone composition for the treatment of menopausal physiological disorders and symptoms |
| 07/09/2008 | EP1941891A1 Preparation for treating non-infectious inflammatory intestinal diseases |
| 07/09/2008 | EP1941889A1 Method for producing sulphated glycosaminoglycans from a biological tissues |
| 07/09/2008 | EP1941887A1 Metallo-fullerenols and its application in preparation of medicines for inhibiting the growth of tumour |
| 07/09/2008 | EP1941886A1 Blister pack of mifepristone and misoprostol |
| 07/09/2008 | EP1941885A2 Homopiperazine compounds that inhibit ribosomal frameshifting by binding to rna pseudoknot structure of sars coronavirus |
| 07/09/2008 | EP1941883A1 Use of sodium blockers for an early therapy of obstructive lung diseases |
| 07/09/2008 | EP1941881A1 Dermatitis remedies |
| 07/09/2008 | EP1941880A1 Lotion preparation containing pyridonecarboxylic acid derivative |
| 07/09/2008 | EP1941879A1 Neuroprotective agent for the treatment of neuronal damage |
| 07/09/2008 | EP1941878A1 Sedative non-benzodiazepine formulations |
| 07/09/2008 | EP1941877A1 Pharmaceutical compositions containing nitrovinylfuran derivatives for the treatment of leishmaniasis and trypanosomiasis |
| 07/09/2008 | EP1941876A1 Isosorbide mononitrate derivatives for the treatment of Inflammation and ocular hypertension |
| 07/09/2008 | EP1941875A1 Use of lipoxin analogs to promote cell defense against gram-negative infections |
| 07/09/2008 | EP1941874A1 Colonic delivery-type therapeutic agent for inflammatory bowel disease |
| 07/09/2008 | EP1941873A1 Metallo-beta-lactamase inhibitor |
| 07/09/2008 | EP1941872A1 Use of TNF-alpha inhibitors for treating nerve root injury |
| 07/09/2008 | EP1941871A1 Formulations for prevention and treatment of breast cancer with 4-hydroxy tamoxifen |
| 07/09/2008 | EP1941870A2 Perfume Composition comprising perilla aldehyde |
| 07/09/2008 | EP1941829A2 Noninvasive measurement of chemical substances |
| 07/09/2008 | EP1941059A2 Compositions and methods for inhibiting expression of huntingtin gene |
| 07/09/2008 | EP1941040A1 Modulation of glucocorticoid receptor expression |
| 07/09/2008 | EP1941036A1 Novel tyrosinase-specific antigenic oligonucleotides as depigmenting agents |
| 07/09/2008 | EP1941012A2 A process for the removal of sterols and other compounds from glycerol oils |
| 07/09/2008 | EP1940916A1 Macromolecular compounds having controlled stoichiometry |
| 07/09/2008 | EP1940877A1 Modified biodegradable polymers, preparation and use thereof for making biomaterials and dressings |
| 07/09/2008 | EP1940863A2 Nitrooxy derivatives op glucocorticoids |
| 07/09/2008 | EP1940862A2 Allele-specific rna interference |
| 07/09/2008 | EP1940848A1 Antimitotic rhizoxin derivatives of burkholderia rhizoxina, method for producing said derivatives and use thereof |
| 07/09/2008 | EP1940847A2 Pyrazolopyrimidines as protein kinase inhibitors |
| 07/09/2008 | EP1940846A2 Pyrimidin-4-yl-3,4-dihydro-2h-pyrrolo[1,2a]pyrazin-1-one compounds |
| 07/09/2008 | EP1940845A1 Novel azetidine compounds useful in the treatment of functional gastrointestinal disorders, ibs and functional dyspepsia |
| 07/09/2008 | EP1940844A2 Compounds and compositions as protein kinase inhibitors |
| 07/09/2008 | EP1940843A2 Unsaturated heterocyclic derivatives |
| 07/09/2008 | EP1940842A2 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
| 07/09/2008 | EP1940840A1 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof |
| 07/09/2008 | EP1940839A1 PYRIDOPYRIMIDINONE INHIBITORS OF PI3Kalpha |
| 07/09/2008 | EP1940838A1 Triazolopyridine derivatives as inhibitors of lipases and phospholipases |
| 07/09/2008 | EP1940837A2 Imidazopyridine compounds |
| 07/09/2008 | EP1940836A1 Pyrazolo[3,4-b]pyridine compound, and its use as a pde4 inhibitor |
| 07/09/2008 | EP1940835A1 Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors |
| 07/09/2008 | EP1940833A1 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof |
| 07/09/2008 | EP1940832A1 Novel 1-aza bicycloalkyl derivatives for the treatment of psychotic and neurodegenerative disorders |
| 07/09/2008 | EP1940831A1 Salicylate and gentisate salts of a piperazine compound |
| 07/09/2008 | EP1940830A1 Glucuronate salt of a piperazine compound |
| 07/09/2008 | EP1940829A2 Imidazole derivatives and their use for modulating the gabaa receptor complex |
| 07/09/2008 | EP1940828A2 Heterocyclic aspartyl protease inhibitors |
| 07/09/2008 | EP1940827A1 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/09/2008 | EP1940826A1 Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/09/2008 | EP1940825A1 Quinazoline derivatives as anticancer agents |
| 07/09/2008 | EP1940824A1 Selected cgrp antagonists method for production and use thereof as medicament |
| 07/09/2008 | EP1940823A2 Substituted 1-amino-phthalzine derivatives, preparation and therapeutic use thereof |
| 07/09/2008 | EP1940822A1 Imidazole derivatives and their use for modulating the gaba-a receptor complex |
| 07/09/2008 | EP1940821A2 Novel vanilloid receptor ligands and their use for producing medicaments |
| 07/09/2008 | EP1940820A1 Midazole-4-carboxamide derivatives for use as cb modulators |
| 07/09/2008 | EP1940819A1 Phosphodiesterase 10 inhibitors |
| 07/09/2008 | EP1940818A1 Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase n inhibitors |
| 07/09/2008 | EP1940817A1 Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment |
| 07/09/2008 | EP1940815A1 Salts of modulators of ppar and methods of treating metabolic disorders |
| 07/09/2008 | EP1940811A1 Heterocyclic compounds with carboxyl isostere groups and their use for the treatment of cardiovascular diseases |
| 07/09/2008 | EP1940810A2 Inhibitors of phosphodiesterase type-iv |
| 07/09/2008 | EP1940809A1 Tetrazol derivatives and their use for the treatment of cardiovascular diseases |
| 07/09/2008 | EP1940808A1 Difluorophenol derivatives and their use |
| 07/09/2008 | EP1940807A1 Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases |
| 07/09/2008 | EP1940804A2 Novel pyrimidine-2,4-diamine derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
| 07/09/2008 | EP1940803A1 1,2-diarylimidazoles for use as cbi modulators |
| 07/09/2008 | EP1940801A2 Imidazole derivatives and their use for modulating the gaba-a receptor complex |
| 07/09/2008 | EP1940800A1 Novel bicyclic sulfonamides for use as glucocorticoid receptor modulators in the treatment of inflammatory diseases |
| 07/09/2008 | EP1940799A1 Pyrazole derivatives, compositions containing such compounds and methods of use |
| 07/09/2008 | EP1940798A1 17-oxymacbecin derivatives and their use in the treatment of cancer and/or b-cell malignancies |
| 07/09/2008 | EP1940797A2 8-substituted benzoazepines as toll-like receptor modulators |
| 07/09/2008 | EP1940796A1 Isoquinolines derivatives as igf-1r inhibitors |
| 07/09/2008 | EP1940795A1 N-oxo-heterocycle and n-oxo-alkyl quinoline-4-carboxamides as nk-3 receptor ligands |
| 07/09/2008 | EP1940794A2 Quinoline derivatives and use as antitumor agents |
| 07/09/2008 | EP1940788A1 1-benzylindole-2-carboxamide derivatives |
| 07/09/2008 | EP1940787A1 Novel ido inhibitors and methods of use thereof |
| 07/09/2008 | EP1940786A1 Biphenyl derivatives and their use in treating hepatitis c |
| 07/09/2008 | EP1940785A2 Acyclic 1,4-diamines and uses thereof |
| 07/09/2008 | EP1940784A2 Halo active aromatic sulfonamide organic compounds and odor control uses therefor |
| 07/09/2008 | EP1940782A1 N-phenyl phenylacetamide non-nucleoside reverse transcriptase inihibitors |
| 07/09/2008 | EP1940781A1 Phenyl-acetamide nnrt inhibitors |
| 07/09/2008 | EP1940777A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands |
| 07/09/2008 | EP1940776A2 Amino-alkyl-amide derivatives as ccr3 receptor ligands |
| 07/09/2008 | EP1940775A2 Methods and compositions for the efficient delivery of therapeutic agents to cells and animals |
| 07/09/2008 | EP1940773A2 Polyamines useful as anti-parasitic and anti-cancer therapeutics and as lysine-specific demethylase inhibitors |
| 07/09/2008 | EP1940772A1 Novel method for preparing quaternary acid and ammonium salts |
| 07/09/2008 | EP1940769A1 Dicarboxylic acid derivatives and their use |
| 07/09/2008 | EP1940768A1 Cyclopropylacetic acid derivatives and use thereof |
| 07/09/2008 | EP1940519A1 Pharmaceutical composition suitable for the treatment of malaria within one day |
| 07/09/2008 | EP1940517A2 Compositions comprising colostrum and hyaluronic acid for the treatment of vaginal dryness |
| 07/09/2008 | EP1940516A2 Benzopyran and pyranopyridine derivatives as potassium channel openers |
| 07/09/2008 | EP1940481A2 Medical devices and coatings therefore comprising biodegradable polymers with enhanced functionality |
| 07/09/2008 | EP1940478A2 Wound-healing pharmaceutical compositions in the form of a sterile powder based on amino acids and sodium hyaluronate |
| 07/09/2008 | EP1940472A1 Composition and method for the prevention, treatment and/or alleviation of an inflammatory disease |
| 07/09/2008 | EP1940467A2 Sustained drug release composition |
| 07/09/2008 | EP1940460A2 Oligodendrocyte-myelin glycoprotein compositions and methods of use thereof |
| 07/09/2008 | EP1940458A1 Compositions for and methods of granzyme b inhibition |
| 07/09/2008 | EP1940454A2 Oral formulation for enteric disorders and/or rehydration |